U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07211425) titled 'A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood' on Oct. 02.
Brief Summary: The main objective of this trial is to investigate the effect of multiple oral doses of the strong CYP3A4 inhibitor itraconazole on the pharmacokinetics of a single dose of BI 3031185 following oral administration.
Study Start Date: Oct. 08
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: BI 3031185
BI 3031185
DRUG: Itraconazole
Itraconazole
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Disclaimer: Curated by HT Syndication....